UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Parsifal Capital Management LP

Parsifal Capital Management LP lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 76.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,900 shares of the healthcare conglomerate’s stock after acquiring an additional 27,700 shares during the period. UnitedHealth Group accounts for 2.7% of Parsifal Capital Management LP’s holdings, making the stock its 13th largest position. Parsifal Capital Management LP’s holdings in UnitedHealth Group were worth $32,324,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares during the last quarter. MCF Advisors LLC grew its position in shares of UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 20 shares in the last quarter. Axiom Financial Strategies LLC boosted its stake in UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after buying an additional 20 shares during the last quarter. Richwood Investment Advisors LLC increased its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after acquiring an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC boosted its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after acquiring an additional 21 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have weighed in on UNH. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 22nd. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 30th. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $311.23 on Wednesday. UnitedHealth Group Incorporated has a one year low of $309.10 and a one year high of $630.73. The business has a 50-day simple moving average of $482.53 and a 200-day simple moving average of $519.28. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $282.33 billion, a PE ratio of 20.08, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the firm posted $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.